These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 34382013)

  • 1. Chemical-genetic CRISPR-Cas9 screens in human cells using a pathway-specific library.
    Hundley FV; Toczyski DP
    STAR Protoc; 2021 Sep; 2(3):100685. PubMed ID: 34382013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimized protocol for gene editing in adipocytes using CRISPR-Cas9 technology.
    Qiu Y; Ding Q
    STAR Protoc; 2021 Mar; 2(1):100307. PubMed ID: 33554142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocol for establishing knockout cell clones by deletion of a large gene fragment using CRISPR-Cas9 with multiple guide RNAs.
    Saito AC; Higashi T; Chiba H
    STAR Protoc; 2024 Sep; 5(3):103179. PubMed ID: 38972040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pooled CRISPR Screens in Drosophila Cells.
    Viswanatha R; Brathwaite R; Hu Y; Li Z; Rodiger J; Merckaert P; Chung V; Mohr SE; Perrimon N
    Curr Protoc Mol Biol; 2019 Dec; 129(1):e111. PubMed ID: 31763777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide CRISPR-Cas9 screening in mammalian cells.
    Yu JSL; Yusa K
    Methods; 2019 Jul; 164-165():29-35. PubMed ID: 31034882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SliceIt: A genome-wide resource and visualization tool to design CRISPR/Cas9 screens for editing protein-RNA interaction sites in the human genome.
    Vemuri S; Srivastava R; Mir Q; Hashemikhabir S; Dong XC; Janga SC
    Methods; 2020 Jun; 178():104-113. PubMed ID: 31494246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, execution, and analysis of pooled in vitro CRISPR/Cas9 screens.
    Miles LA; Garippa RJ; Poirier JT
    FEBS J; 2016 Sep; 283(17):3170-80. PubMed ID: 27250066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR deactivation in mammalian cells using photocleavable guide RNAs.
    Zou RS; Liu Y; Ha T
    STAR Protoc; 2021 Dec; 2(4):100909. PubMed ID: 34746867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protocol for the saturation and multiplexing of genetic variants using CRISPR-Cas9.
    Sahu S; Sullivan T; Southon E; Caylor D; Geh J; Sharan SK
    STAR Protoc; 2023 Dec; 4(4):102702. PubMed ID: 37948185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9-Based Gene Dropout Screens.
    Wu K; Malek SN
    Methods Mol Biol; 2019; 1881():185-200. PubMed ID: 30350207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol for in vivo CRISPR screening using selective CRISPR antigen removal lentiviral vectors.
    Lane-Reticker SK; Kessler EA; Muscato AJ; Kim SY; Doench JG; Yates KB; Manguso RT; Dubrot J
    STAR Protoc; 2023 Mar; 4(1):102082. PubMed ID: 36861834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening Regulatory Element Function with CRISPR/Cas9-based Epigenome Editing.
    Klann TS; Crawford GE; Reddy TE; Gersbach CA
    Methods Mol Biol; 2018; 1767():447-480. PubMed ID: 29524151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generating mutant
    Li HH; Li JC; Su MP; Liu KL; Chen CH
    STAR Protoc; 2021 Jun; 2(2):100432. PubMed ID: 33899015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Drug Resistance Mechanisms Using Genome-Wide CRISPR-Cas9 Screens.
    MacLeod G; Rajakulendran N; Angers S
    Methods Mol Biol; 2022; 2535():141-156. PubMed ID: 35867229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilizing CRISPR/Cas9 technology to prepare lymphoblastoid cell lines harboring genetic mutations for generating quality control materials in genetic testing.
    Zhou L; Li R; Zhang R; Peng R; Chen K; Gao P; Zhang J; Zhang R; Li J
    J Clin Lab Anal; 2020 Jul; 34(7):e23256. PubMed ID: 32118319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensible combinatorial CRISPR screening in mammalian cells.
    Zhou P; Wan YK; Chan BKC; Choi GCG; Wong ASL
    STAR Protoc; 2021 Mar; 2(1):100255. PubMed ID: 33490975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heritable CRISPR-Cas9 editing of plant genomes using RNA virus vectors.
    Uranga M; Aragonés V; Daròs JA; Pasin F
    STAR Protoc; 2023 Mar; 4(1):102091. PubMed ID: 36853698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimized CRISPR/Cas9-mediated single nucleotide mutation in adherent cancer cell lines.
    Gao P; Dong X; Wang Y; Wei GH
    STAR Protoc; 2021 Jun; 2(2):100419. PubMed ID: 33870225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High content analysis platform for optimization of lipid mediated CRISPR-Cas9 delivery strategies in human cells.
    Steyer B; Carlson-Stevermer J; Angenent-Mari N; Khalil A; Harkness T; Saha K
    Acta Biomater; 2016 Apr; 34():143-158. PubMed ID: 26747759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput genetic screens using CRISPR-Cas9 system.
    Kweon J; Kim Y
    Arch Pharm Res; 2018 Sep; 41(9):875-884. PubMed ID: 29637495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.